CAS No. |
1644539-04-7 |
|---|---|
英文名称 |
- |
别名 |
Eptinezumab;Research Grade Eptinezumab(DHC22403);Eptinezumab (anti-CGRP);Research Grade Eptinezumab |
用途 |
Eptinezumab is a calcitonin gene-related peptide (CGRP) monoclonal antibody approved by the FDA in February 2020 for the preventive treatment of migraine in adults. |
|
|
评论 |
|---|